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Autophagy is an essential cellular mechanism that
degrades cytoplasmic proteins and organelles to
recycle their components. Here we show that auto-
phagy is required for reprogramming of somatic cells
to form induced pluripotent stem cells (iPSCs). Our
data indicate that mammalian target of rapamycin
(mTOR) is downregulated by Sox2 at an early stage
of iPSC generation and that this transient down-
regulation of mTOR is required for reprogramming
to take place. In the absence of Sox2, mTOR remains
at a high level and inhibits autophagy. Mechanis-
tically, Sox2 binds to a repressive region on the
mTOR promoter and recruits the NuRD complex to
mediate transcriptional repression.We also detected
enhanced autophagy at the four- to eight-cell stage
of embryonic development, and a similar Sox2 and
mTOR-mediated regulatory pathway seems to oper-
ate in this context as well. Thus, our findings reveal
Sox2-dependent temporal regulation of autophagy
as a key step in cellular reprogramming processes.
INTRODUCTION
Macroautophagy (hereafter referred to as autophagy) is an evolu-
tionarily conserved process that degrades cytoplasmic proteins
and organelles to recycle cellular components for cell survival
and tissue homeostasis (He and Klionsky, 2009; Kundu and
Thompson, 2008). Via double-membraned autophagosomes,
long-lived proteins or unwanted organelles are hydrolyzed, and
amino acids can be reused for cell renovation (Mizushima and
Komatsu, 2011; Mizushima and Levine, 2010). Autophagy pro-
vides a recycling system that plays a key role in cellular homeo-
stasis (Mizushima and Komatsu, 2011), tumor suppression
(Wanget al., 2012a), antigen processing (Nedjic et al., 2008), anti-
neurodegeneration (Lee et al., 2010), and embryonic develop-
ment (Mizushima and Levine, 2010). However, it is not yet known
whether autophagy is involved in cellular reprogramming.
Somatic cell reprogramming involves epigenetic modification,
changes in gene expression, protein degradation, and protein
synthesis. Reprogramming resets differentiated cells to a plurip-
otent state and can be achieved by nuclear transfer, cell fusion,Cellor transduction of certain transcription factors (Yamanaka and
Blau, 2010). Originally, four core transcriptional factors (Oct4,
Sox2, Klf4 and c-Myc, termed OSKM) were identified as being
able to convert differentiated fibroblasts into induced pluripotent
stem cells (iPSCs) (Takahashi et al., 2007; Takahashi and Yama-
naka, 2006; Yu et al., 2007). Subsequently, various methodo-
logical changes were made to improve efficiency and reduce
carcinogenesis risk during iPSC induction (Yamanaka, 2012).
Despite the remarkable progress in reprogramming technology,
the underlying molecular mechanisms remain largely elusive.
Recently, several reports showed that epigenetic modification
starts at an early stage of cell reprogramming, initiating rear-
rangement of gene expression profiles (Doege et al., 2012; Gu
et al., 2011; Koche et al., 2011). Genome-wide analyses and
in-depth quantitative proteomics reveal that during the first
3 days of reprogramming, multiple protein profile changes occur
in a highly coordinated fashion (Buganim et al., 2012; Golipour
et al., 2012; Polo et al., 2012), suggesting that there may be
relationships between epigenetic modifications and protein
degradation and synthesis. Here we show that autophagy is
essential for cell reprogramming. Mechanistically, we show
that Sox2 recruits the nucleosome remodeling and deacetylase
(NuRD) complex to repress mTOR expression and promote
cellular reprogramming through induction of autophagy.RESULTS
Autophagy Is Required for iPSC Generation
To examine the role of autophagy in somatic cell reprogram-
ming, we generated Atg5+/+ and Atg5/ mouse embryonic
fibroblasts (MEFs) containing drug-inducible OSKM factors
(Carey et al., 2010) (referred to as 4F2A MEFs hereafter). Atg5
plays a key role in autophagosome formation (Sakoh-Nakato-
gawa et al., 2013). We found that 3 weeks after initiating culture
in embryonic stem cell (ESC) media containing doxycycline,
iPSC colonies formed from Atg5+/+ 4F2A MEFs, but not from
Atg5/ 4F2A MEFs (Figure 1A), despite comparable expres-
sion of the OSKM factors (Figure S1A available online). The
iPSCs generated from Atg5+/+ 4F2A MEFs expressed pluripo-
tency markers (Figure 1A and Figure S1B) and were able to
form teratomas containing cells of all three germ layers (Fig-
ure 1B). Atg3 and Atg7 are also required for autophagosome
formation (Weidberg et al., 2011). We also found that depletion
of Atg3 or Atg7 impaired autophagy and abrogated iPSC forma-
tion (Figures S1C and S1D). Restoration of Atg3 or Atg7 intoStem Cell 13, 617–625, November 7, 2013 ª2013 Elsevier Inc. 617
Figure 1. Autophagy Is Essential for iPSC
Generation
(A) Atg5 deficiency impairs iPSC formation.
Atg5+/+ or Atg5/ MEFs carrying drug-inducible
OSKM factors (hereinafter referred to as 4F2A
MEFs) were cultured in ESC media containing
2 mg/ml doxycycline for 3 weeks and detected for
alkaline phosphatase (AP) activity (upper panel)
or stained with anti-SSEA-1 antibody (lower
panel). Colony numbers per 104 cells were
calculated and shown as mean ± SD. ***p <
0.001.
(B) iPSCs from Atg5+/+, but not Atg5/; 4F2A
MEFs, can form teratomas. Atg5+/+ or Atg5/;
4F2A MEFs treated as above were harvested and
subcutaneously injected into NOD-SCID mice.
One month later, teratomas were collected for
H&E staining. EN, endoderm; ME, mesoderm; EC.
ectoderm. Scale bar, 200 mm.
(C) Autophagy in iPSC formation. GFP-LC3; 4F2A
MEFs were treated with doxycycline for the indi-
cated days and immunostained by anti-Sox2
antibody. Nuclei were visualized by DAPI. GFP-
LC3 dots per cell were calculated and shown as
mean ± SD. **p < 0.01; ***p < 0.001. Scale bar,
10 mm.
(D) Autophagic flux during iPSC generation. WT
4F2A MEFs were treated with doxycycline for the
indicated days and harvested for immunoblotting.
(E) Autophagosomal structures appear during
iPSC generation. WT 4F2A MEFs were cultured in
doxycycline-contained ESC media and autopha-
gosomes were analyzed by electron microscopy
and shown as mean ± SD. **p < 0.01; ***p < 0.001.
Red arrowhead indicates autophagosome. Scale
bar, 500 nm.
(F) Autophagy is enhanced at the four- to
eight-cell stage during embryonic development.
Embryos at the indicated stages from GFP-LC3
transgenic mice were isolated, and cultured in
OSKM media with or without 20 nM Bafilomycin
A1 (BafA1) for 4 hr, and visualized by confocal
microscopy. Scale bar, 20 mm.
(G) Rapamycin promotes reprogramming of embryos. Embryos were isolated at embryo day (E) 1.5 and cultured in OSKMmedia. One microgram per milliliter of
rapamycin was added into culture at E2.5 for 4 hr. Distribution of embryonic stage at E3.0 was calculated as mean ± SD (right panel). **p < 0.01. Red arrow
indicates blastocyst. Scale bar, 100 mm.
See also Figure S1.
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and restored their capacity to generate iPSCs (Figures S1C
and S1D). Overall, these indicate that autophagy is required
for iPSC generation. We used 4F2A MEFs expressing green
fluorescent protein (GFP) fused LC3 (GFP-LC3), an autophago-
some marker protein, to monitor autophagic activity during re-
programming. Surprisingly, autophagosomes appeared at the
first day after OSKM induction and peaked on the following
day (Figure 1C). The autophagic flux was verified by conversion
of LC3-II and degradation of p62, an autophagic substrate
(Mathew et al., 2009) (Figure 1D), and autophagosomal struc-
tures were observed by electron microscopy (Figure 1E). Induc-
tion of autophagy did not occur in wild-type (WT) MEFs after
treatment with doxycycline alone (Figure S1E). In addition, we
verified that Atg5-deficient cells failed to reduce mitochondrial
numbers and reactive oxygen species (ROS) levels after
OSKM induction (Figures S1F–S1H), changes that are also618 Cell Stem Cell 13, 617–625, November 7, 2013 ª2013 Elsevier Inviewed as being hallmarks of the establishment of pluripotency
(Sena and Chandel, 2012).
A previous study showed that Atg5-deficient oocytes could
not develop to the four- to eight-cell stage after fertilization
with Atg5 null sperm (Tsukamoto et al., 2008). We also examined
embryos at this stage, and found that the level of GFP-LC3
protein reduced rapidly at the four- to eight-cell stage of WT
embryos, indicating active autophagy, and was restored by the
autophagy inhibitor Bafilomycin A1 (BafA1) (Figure 1F). When
we treated embryos with rapamycin to induce autophagy at
the four-cell stage, blastocysts appeared as early as embryo
day (E) 3.0 (Figure 1G), suggesting that autophagy induction
also promotes embryonic development.
Sox2 Initiates Autophagy during Cell Reprogramming
The overall gene expression profile of cells changes substantially
during reprogramming (Buganim et al., 2012). To explore whichc.
Cell Stem Cell
Autophagy Is Required for iPSC Generationfactors contribute to autophagy induction, we analyzed the
mRNA levels of various autophagy-related genes (Atg) at an early
stage of iPSC formation. However, all of the Atg genes that we
examined showed no significant change after iPSC induction
(Figure S2A). We also evaluated the expression levels of genes
that are important for autophagy modulation. Interestingly, we
observed that mTOR mRNA dramatically declined on the first
day of OSKM expression (Figure S2B). The mTOR protein level
was also repressed for the first two days of the reprogramming
process (Figure S2C) but was then restored to basal levels at
day 3 of iPSC generation. mTOR exists in two distinct com-
plexes, mTORC1 and mTORC2 (Zoncu et al., 2011). mTORC1
phosphorylates S6K at Thr389 and mTORC2 phosphorylates
AKT at Ser473 to facilitate the phosphorylation of AKT at
Thr308 (Sarbassov et al., 2005; Zoncu et al., 2011). We found
that phosphorylation of both AKT and S6K was completely sup-
pressed during early reprogramming (Figure S2C), indicating
that both mTORC1 and mTORC2 are inhibited. Consistent with
this observation we also found that polysomes were reduced
during the initial days of reprogramming (Figure S2D). Autophagy
could be blocked by ectopic expression of WT mTOR but not
kinase-dead mTOR (mTOR-KD, an inactive form of mTOR;
Brunn et al., 1997) during iPSC induction (Figure S2E). Of note,
transient overexpression of WT mTOR blocked iPSC formation,
but mTOR-KD had no such activity (Figure S2F). Moreover, the
efficiency of iPSC generation could be improved by adding the
mTOR inhibitor rapamycin on day 1 of doxycycline induction
(Figure S2G). Addition of LY294002, a reversible inhibitor of
PI3Ks (Walker et al., 2000) that inhibits autophagy by blocking
the activity of Beclin 1-Vps34 complex (Figure S2H), also
impaired iPSC generation. The timing of inhibition was also
important. When we treated 4F2AMEFs with rapamycin to block
mTOR 3 days after doxycycline induction, no iPSCs were
obtained (Figure S2I). These data suggest that an initial short
burst of mTOR suppression at an early stage and then restora-
tion of mTOR activity at a later stage are both required for suc-
cessful reprogramming to take place.
We next analyzed the role of each of the four pluripotency fac-
tors in regulation of mTOR expression. Interestingly, ectopic
expression of Sox2 dramatically suppressed mTOR expression
and promoted the induction of autophagy (Figures 2A–2C), like
OSKM expression. However, the other three factors did not
impact mTOR expression or autophagy induction (Figures 2A
and 2B and Figure S2J). Additionally, we found that Sox2 over-
expression could not suppress mTOR expression in HeLa or
HEK293T cells (Figure S2K), and we therefore propose that
this activity is only manifest during reprogramming. Under phys-
iological conditions, Sox2 is required for the derivation of ESCs,
and Sox2 deficiency leads to early embryonic lethality (Avilion
et al., 2003; Keramari et al., 2010; Masui et al., 2007). We found
that maternal Sox2 protein persisted in the nucleus and cyto-
plasm of zygotes during embryonic development (Figure 2D),
and nuclear Sox2 rose at the four- to eight-cell stage, accompa-
nied with downregulation of mTOR expression (Figures 2D and
2E). Correspondingly, enhanced autophagy occurred at this
stage (Figure 1F). We derived Sox2+/+; GFP-LC3 and Sox2/;
GFP-LC3 embryos through mating of Sox2+/; EIIa-Cre; GFP-
LC3 females with Sox2flox/+ males. In Sox2/ embryos, we
found that autophagy was impaired (Figure 2F), and the mTORCellprotein level was not reduced at the four- to eight-cell stage
(Figure 2G). These data are consistent with the idea that Sox2
initiates autophagy by suppressing mTOR expression during
the cellular reprogramming that occurs in early embryogenesis.
Sox2 SuppressesmTOR Expression through
Recruitment of NuRD Complex
Sox2 contains a high-mobility-group (HMG) domain, which
binds DNA in a sequence-specific manner (Sarkar and Hoched-
linger, 2013). We analyzed a 5-kilobase (kb) locus upstream
from transcription start sites (TSS) of the mTOR gene. Using
chromatin immunoprecipitation (ChIP), we found that
a 2,2001,200 base pair (bp) region of the mTOR promoter
upstream from the TSS was occupied by Sox2 protein (Fig-
ure 3A). To verify that mTOR transcriptional activity is inhibited
by Sox2, we used luciferase reporter constructs. Based on these
experiments, we identified a 1,8001,600 bp fragment of an
mTOR promoter as a repressive region where Sox2 bound (Fig-
ures 3B and 3C). We then mapped the binding locus on the
mTOR promoter by electrophoretic mobility shift assay (EMSA)
with different oligos from the 1,8201,581 bp fragment,
and we determined that the 1,6601,621 bp region of the
mTOR promoter contains the Sox2 binding locus (Figures 3D
and 3E). To investigate a physiological function of this repressive
region, we employed transcription activator-like effector
nuclease (TALEN) technology to delete the Sox2 binding locus
on the mTOR promoter (DmTOR) in MEFs (Figures S3A and
S3B). As expected, the binding of Sox2 was abrogated in
DmTOR MEFs (Figure 3F). The expression levels of OSKM in
DmTOR; 4F2A MEFs were similar to those of WT 4F2A MEFs
(Figure S3C). However, deletion of the repressive locus restored
both the mRNA and protein levels of mTOR during early iPSC in-
duction (Figure 3G and Figure S3D) with inhibition of autophagy
as a result (Figures 3G and 3H).We treated theDmTOR cells with
rapamycin during the first 2 days of reprogramming and restored
the expected level of autophagy (data not shown). Importantly,
we did not see production of iPSCs in DmTOR cells, and this
capacity was also restored by rapamycin treatment (Figure 3I).
These data suggest that mTOR suppression at an early stage
is essential for reprogramming to pluripotency to take place.
To support this conclusion further, we generated an inducible
knockdown system for mTOR in DmTOR MEFs to determine
whether silencing of mTOR can rescue reprogramming in these
cells. We treated inducible shmTOR DmTORMEFs with doxycy-
cline to induce the silencing of mTOR during the first 2 days of
reprogramming but also the expression of Oct4, c-Myc, and
Klf4 (without Sox2). After 2 days’ treatment, Sox2 was also
added and mTOR was returned to basal levels by the removal
of doxycycline (Figure S3E). Since we used DmTOR cells,
Sox2 could not downregulate mTOR. As expected, iPSCs ap-
peared from shmTOR DmTOR MEFs (Figure S3F). These data
indicate that silencing of mTOR in the absence of Sox2 at an
early stage of reprogramming is sufficient for iPSC generation.
To examine the role of mTORC1 andmTORC2 in cell reprogram-
ming, we knocked down Raptor and Rictor separately. We found
that silencing of Raptor, but not Rictor, in DmTOR cells at the
early stage of reprogramming could rescue iPSC generation in
DmTOR cells (Figure S3G), suggesting that inhibition ofmTORC1
is essential for cellular reprogramming. In sum, therefore, Sox2Stem Cell 13, 617–625, November 7, 2013 ª2013 Elsevier Inc. 619
Figure 2. Sox2 Contributes to Autophagy Initiation during iPSC Formation
(A) Sox2 downregulatesmTORmRNAduring iPSC formation.WTMEFswere infectedwith retrovirus encodingOSKM factors together or individually and cultured
in ESC media for 24 hr. mRNA levels of the indicated genes were analyzed by RT-PCR. Data are representative of three different experiments and shown as
mean ± SD. **p < 0.01.
(B) Sox2 contributes to mTOR repression. WT MEFs treated as above were harvested and subjected to immunoblotting with the indicated antibodies.
(C) Sox2 initiates autophagy. GFP-LC3 MEFs were infected with retrovirus encoding Sox2 or empty vector (Ctrl) and cultured in ESC media for 48 hr, and GFP-
LC3 dots were analyzed by confocal microscopy (upper panel) and calculated as mean ± SD (lower panel). ***p < 0.001. Scale bar, 10 mm.
(D) mTOR is downregulated at the four- to eight-cell stage of embryos. Embryos at the indicated stages were isolated and subjected to immunostaining. Nuclei
were visualized by DAPI. Scale bar, 20 mm.
(E) Transcription ofmTOR is impaired at the four- to eight-cell stage. Embryos at the two-cell stage (E1.5) or the four- to eight-cell stage (E2.5) were isolated and
harvested for mRNA extraction for RT-PCR. Data are representative of three independent experiments and are shown as mean ± SD.
(F) Autophagy is defective inSox2/ embryos. Embryos from Sox2+/; EIIa-Cre;GFP-LC3 femalesmatedwithSox2flox/+males were isolated for immunostaining.
Scale bar, 20 mm.
(G) Sox2 deficiency potentiates mTOR expression. Embryos from Sox2+/; EIIa-Cre females mated with Sox2flox/+ males were harvested for immunostaining.
Scale bar, 20 mm. We used two different anti-mTOR antibodies (#2972 and #2983, Cell Signaling Technology) for immunoblotting and two different anti-mTOR
antibodies (#2983 from Cell Signaling Technology and #sc-8319 from Santa Cruz Biotechnology) for immunofluorescent staining and received similar results.
See also Figure S2.
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Autophagy Is Required for iPSC Generationoccupies a specific region on the mTOR promoter to suppress
mTOR transcription, leading to initiation of autophagy during
iPSC generation.
To explore the mechanism of Sox2-mediated inactivation of
mTOR transcription, we generated an affinity resin coupled
with the1,6601,621 bpDNA segment and used DNA affinity
chromatography to screen for associated proteins that specif-
ically bind to the 40 nucleotides. Notably, several components
of the NuRD complex were pulled down from nuclear extracts
of MEFs expressing Sox2 (Figure 4A and Figure S4A). The major
identified components of NuRD complex (includingMi-2b, LSD1,620 Cell Stem Cell 13, 617–625, November 7, 2013 ª2013 Elsevier InMTA2, andHDAC1) were confirmed by immunoblotting with their
specific antibodies (Figure 4B). Sox2 could also precipitate the
major components of NuRD complex in vivo through an immuno-
precipitation assay (Figure 4C).
Previous studies have shown that the NuRD complex is a tran-
scriptional repressor that is recruited to gene promoters through
interaction with a DNA sequence-specific transcription factor for
chromatin remodeling and histone modification (Hu and Wade,
2012). The NuRD complex contributes to deacetylation and
demethylation of histones (Wang et al., 2009), which is essential
for pluripotency of ESCs (Adamo et al., 2011; Kaji et al., 2006;c.
Figure 3. Sox2 Targets mTOR Promoter to Repress Its Expression
(A) Sox2 is recruited to the mTOR promoter. ChIP analysis monitored binding of Sox2 to mTOR promoter in MEFs expressing empty vector (Ctrl) or Sox2. Data
represent at least three separate experiments and are shown as mean ± SD. **p < 0.01.
(B andC) Sox2 suppressesmTOR transcription. Different loci of themTOR promoter were constructed into pGL3 vector, transfected intoMEFs expressing empty
vector (Ctrl) or Sox2, and subjected to luciferase reporter assay. Data are representative of three different experiments and are shown as mean ± SD. **p < 0.01.
(D) Sox2 binds to themTOR promoter. Nuclear extracts fromMEFs expressing Sox2 were monitored by EMSA assay with different probes as shown in the upper
panel.
(E) Sox2 binds a specific locus on themTOR promoter. EMSA assay monitored Sox2 binding ofmTOR promoter with the specific 40 nucleotide probe (#2 probe
as in 3D) with nuclear extracts fromMEFs expressing empty vector (Ctrl) or Sox2. Anti-Sox2 antibody was added for supershift assay, and unlabeled probes were
added for competitive reaction.
(F) The repressive locus deletion (DmTOR) abolishes Sox2 binding to mTOR promoter. WT or DmTOR MEFs expressing empty vector (Ctrl) or Sox2 were
subjected to ChIP assay by our use of anti-Sox2 antibody. Data are representative of three independent experiments and are shown as mean ± SD. **p < 0.01.
(G) DmTOR abrogates mTOR downregulation and autophagy. WT or DmTOR; 4F2AMEFs were cultured in doxycycline-contained ESC media for the indicated
days and harvested for immunoblotting.
(H)mTOR expression and autophagy induction are impaired inDmTORMEFs.WT orDmTOR;GFP-LC3; 4F2AMEFswere cultured in doxycycline-contained ESC
media for 48 hr and subjected to immunostaining. Scale bar, 10 mm.
(I) iPSC generation is blocked inDmTORMEFs. 4F2AWT or 4F2A; DmTORMEFs were treated with or without 1 mg/ml rapamycin (Rapa) for 48 hr and cultured in
ESC media containing doxycycline for 3 weeks. The iPSCs were visualized by AP staining. Data are representative of three different experiments and are shown
as mean ± SD. ***p < 0.001. Similar results were obtained by using two different anti-mTOR antibodies for immunoblotting and immunofluorescence assays as
described above.
See also Figure S3.
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Figure 4. Sox2 Recruits the NuRD Complex to Inhibit mTOR Transcription
(A) Identification of NuRD complex by a DNA pulldown assay. The binding region (40 nt) on themTOR promoter of Sox2was conjugated to CNBr activated beads.
Nuclear extracts from MEFs expressing GFP or Sox2 were incubated with DNA-conjugated beads for 20 min and the precipitates were subjected to SDS-PAGE
for silver staining and mass spectrometry. M, molecular weight (MW) marker.
(B) The identified components of the NuRD complex were confirmed by western blotting.
(C) Sox2 can precipitate the NuRD complex in vivo. MEFs expressing GFP or Sox2 were harvested for immunoprecipitation with anti-Sox2 antibody. Immu-
noprecipitates were detected by immunoblotting with the indicated antibodies.
(D) Silencing of NuRD complex components restores mTOR mRNA levels. MEFs were infected with retrovirus encoding shRNA against scramble sequence
(shCtrl) or components of NuRD complex, as well as Sox2 or empty vector, and cultured in ESC media for 24 hr followed by RT-PCR analysis. Data are
representative of at least three experiments and are shown as mean ± SD. **p < 0.01.
(E) The NuRD complex is required for autophagy flux induced by Sox2. MEFs were infected with retrovirus encoding the indicated shRNA and Sox2 or empty
vector, cultured in ESC media for 24 hr, and harvested for immunoblotting. b-actin was used as a loading control.
(F) The NuRD complex is recruited tomTOR promoter during early embryonic development. Embryos from the two-cell stage or the four- to eight-cell stage were
determined by ChIP analysis. Data represent three separate experiments and are shown as mean ± SD. **p < 0.01.
(G and H) Knockdown of NuRD complex components impairs mTOR downregulation at the four- to eight-cell stage of embryos. Mi-2b (G) or LSD1 (H) was
silenced with siRNA duplexes at E1.5. Embryos were cultured in OSKMmedia for 24 hr and subjected to immunostaining. Scale bar, 20 mm. Similar results were
obtained by using two different anti-mTOR antibodies for immunoblotting and immunofluorescence assays as described above.
See also Figure S4.
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Autophagy Is Required for iPSC GenerationZhu et al., 2009). However, its functions in somatic cell program-
ming are unclear. Using ChIP assays, we found that Sox2 could
recruit the NuRD complex to the mTOR promoter (Figure S4B).
Consistently, the NuRD complex suppressed the addition of
H3K9K14ac and H3K4me1 transcriptional activation marks on
the mTOR promoter (Figure S4B). We knocked down compo-
nents of the NuRD complex individually and found that depletion
of eachNuRDcomponent resulted in restoration ofmTORmRNA
(Figure 4D). Intriguingly, knockdown of NuRD complex compo-
nents also restored the mTOR protein level and abrogated
Sox2-mediated autophagy induction (Figure 4E and Figure S4C).
We then looked at the binding of the NuRD complex to themTOR
promoter at 3 days after the initiation of iPSC induction, and we
found that theNuRDcomplex disassociated from themTOR pro-
moter at this time (Figure S4D) and that H3K4me1 and
H3K9K14ac returned to basal levels at that later stage. These
data suggest that dynamic binding of NuRD complex to the
mTOR promoter correlates with the restoration of mTOR during
the reprogramming process. Furthermore, disruption of the
NuRD complex impaired iPSC formation (Figure S4E). We also
silenced mTOR during the initial reprogramming period in
NuRD-complex-silenced cells and found that reprogramming
was again rescued (Figure S4F). Together, these results suggest
that NuRD-complex-mediated suppression of mTOR transcrip-
tion contributes to somatic cell reprogramming.
We then looked at binding of the NuRD complex to themTOR
promoter during embryonic development. We found that the
NuRD complex was recruited to the mTOR promoter at the
four- to eight-cell stage (Figure 4F), and H3K9K14ac and
H3K4me1 were substantially reduced at the mTOR promoter.
Notably, silencing of NuRD complex components in embryos
at the four- to eight-cell stage maintained the mTOR protein
level (Figures 4G and 4H and Figure S4G). These data indicate
that NuRD-complex-mediated suppression of mTOR is also
involved in early embryonic development and is likely to be
the relevant mechanism for autophagy induction in this context
as well.
DISCUSSION
In this study, we outline a pathway in which Sox2-mediated
suppression of mTOR expression leads to a transient increase
in autophagy early in the reprogramming process that is required
for successful reprogramming to take place. mTOR is a key
modulator of aging, protein synthesis, glycolysis, and autophagy
(Johnson et al., 2013). Previous studies on the role of mTOR in
reprogramming have led to some apparently contradictory find-
ings. For example, He et al. found that Tsc2 deficiency and high
concentrations of rapamycin both blocked generation of iPSCs
(He et al., 2012). Our study provides a molecular explanation
for this observation by showing that an initial short burst of
mTOR suppression at an early stage and mTOR activity restora-
tion at a later stage are both required for reprogramming to
be completed successfully. Our findings also reveal that the
dynamic repression and restoration of mTOR activity are pre-
cisely regulated by the Sox2-NuRD complex during the reprog-
ramming process. Further studies are needed to elucidate the
underlying mechanism that mediates termination of mTOR
suppression and autophagy.CellSome of our results regarding mTOR expression during early
embryogenesis differ from those reported previously. Gonza´lez
et al. (2012) showed that mTOR protein levels were consistent
from oocyte to blastocyst. However, these two studies used
different mouse strains. We used C57BL/6 mice, while Gonza´lez
et al. used ICRmice. It is possible that strain-specific differences
in mTOR epitope detection or early embryogenesis pathways
could contribute to the difference in results, particularly because
the efficiency of ESC derivation is known to differ between
mouse strains (Hanna et al., 2010).
Sox2 is a core factor for cell reprogramming. We found that
Sox2 occupies a 1,6601,621 bp segment upstream of the
TSS of the mTOR gene during the early stages of reprogram-
ming. Our data indicate that Sox2 recruits the NuRD complex
that downregulates H3K9K14ac and H3K4me1, leading to
transcriptional inhibition of mTOR. Silencing of NuRD complex
components impaired the repression of mTOR expression
and induction of autophagy. After initiation of cellular reprog-
ramming, the NuRD complex disassociates from the mTOR
promoter to restore mTOR expression for the rest of the reprog-
ramming process. Our findings therefore reveal that the NuRD
complex participates in the regulation of somatic cell reprogram-
ming. In addition, the NuRD complex is essential for embryonic
development and deficiency of the NuRD complex causes early
embryonic lethality (Hu and Wade, 2012). During embryonic
development, we found that the NuRD complex downregulated
H3K9K14ac and H3K4me1 of themTOR promoter, and silencing
of NuRD components restored the mTOR protein level, suggest-
ing that the NuRD complex epigenetically regulates the mTOR
promoter in a manner that is essential for embryonic cellular
reprogramming. Further understanding of the mechanisms of
somatic reprogramming will help us not only to promote effi-
ciency of iPSC generation but also to shed light on the develop-
mental biology of early embryogenesis.
EXPERIMENTAL PROCEDURES
Generation of iPSCs
MEFs were obtained at E14.5 of 4F2A embryos, GFP-LC3; 4F2A embryos, or
Atg5/; 4F2A embryos and supplied with Dulbecco’s modified Eagle’s
medium (DMEM) (Invitrogen) with 15% FBS, 100 mg/ml streptomycin, and
100 U/ml penicillin. After one passage, MEFs were plated on a 6-well dish
and cultured in ESC media containing 2 mg/ml doxycycline. After 7 days,
MEFs were plated on mitomycinC-treated B6 MEF feeders. After 3 weeks
in ESC media containing doxycycline, iPSC colonies were analyzed by an
alkaline phosphatase detection kit (Millipore).
Generation of Atg5+/+ and Atg5–/– MEFs
Atg5flox/flox mice were crossed with EIIa-Cre mice to obtain Atg5+/ mice.
Atg5+/mice were crossed with 4F2A transgenic mice orGFP-LC3 transgenic
mice to obtain 4F2A;Atg5+/ andGFP-LC3;Atg5+/mice. Next, 4F2A;Atg5+/
mice were crossed with GFP-LC3; Atg5+/ mice. The pregnant mice were
sacrificed and E14.5 embryos were isolated and digested into single MEFs.
The genotypes of MEFs (4F2A; GFP-LC3; Atg5+/+ MEFs and 4F2A; GFP-
LC3; Atg5/ MEFs) were analyzed by PCR.
Immunofluorescence Assay
Immunofluorescence assays were performed as previously described (Wang
et al., 2012b; Xia et al., 2013). Briefly, MEFs were grown on 0.01% poly-L-
Lysine-treated coverslips and infected with retrovirus encoding the indicated
proteins for 24 hr. Next, cells were fixed with 4% paraformaldehyde (PFA)
(Sigma-Aldrich) for 20 min at room temperature (RT) followed by permeabiliza-
tion with 0.5% Triton X-100 for 20 min at RT. Ten percent donkey serum wasStem Cell 13, 617–625, November 7, 2013 ª2013 Elsevier Inc. 623
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Autophagy Is Required for iPSC Generationused for blocking followed by incubation of primary antibodies for 2 hr at RT.
After being washed three times with PBS, the coverslips were stained with
Alexa 488-, Alexa 594-, or Alexa 405-conjugated secondary antibodies. For
embryonic assay, embryos were collected from pregnant mice at the indicated
times, treated with acidic tyrode for 30 s to remove zona pellucid, fixed with
4% PFA for 20 min at RT, and permeabilized with 0.5% Triton X-100 in PBS
for 20 min at RT. After being blocked with 10% donkey serum, embryos
were incubated with primary antibodies at 4C overnight and then with sec-
ondary antibodies for 1 hr at RT. Images were visualized by laser scanning
confocal microscopy (Olympus FV500).
Statistical Analysis
Student’s t test was used as statistical analysis through our use of Sigma Plot.
For other methods see the Supplemental Information.
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